Lazanda Approval History
- FDA approved: Yes (First approved June 30th, 2011)
- Brand name: Lazanda
- Generic name: fentanyl
- Previous name: NasalFent
- Company: Archimedes Pharma
- Treatment for: Pain
Lazanda (fentanyl) is an opioid analgesic nasal spray for the management of breakthrough pain in cancer patients.
Development History and FDA Approval Process for Lazanda
|Jun 30, 2011||FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients|
|Sep 7, 2009||Archimedes Announces US Filing of NasalFent for the treatment of Breakthrough Cancer Pain|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.